Madrigal Pharmaceuticals, Inc.2024财年第三财季实现净利润-1.07亿美元,同比减少8.37%

市场透视
09 Nov 2024
Madrigal Pharmaceuticals0.00%Post-market

11月10日,Madrigal Pharmaceuticals, Inc.(MDGL.US)公布财报,公告显示公司2024财年第三财季净利润为-1.07亿美元,同比减少8.37%;其中营业收入为62.18百万美元,每股基本收益为-4.92美元。从资产负债表来看,Madrigal Pharmaceuticals, Inc.(MDGL.US)总负债2.96亿美元,其中短期债务878000.00美元,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."